Mukhtar, S. and Haris, M. (2023) “Teplizumab: an FDA- approved drug, marks milestone in treatment of type 1 diabetes ”, International Journal of Scientific Reports, 10(1), pp. 29–30. doi: 10.18203/issn.2454-2156.IntJSciRep20233870.